The workshop, Approaches to Expediting HIV Vaccine Efficacy Evaluation, was held in April 2007 and included 42 participants. The group discussed how to interpret forthcoming results from intermediate-sized vaccine efficacy trials, as well as the advantages and disadvantages of different clinical trial designs. Participants identified the need to expedite product testing in an industry-like manner and more clearly define criteria for selecting appropriate trial designs for different candidates.
A summary of the workshop is available in Section II of the Enterprise Report of Activities 2005-2007
Working Group Participants
|
|
*Workshop Organizing Committee Members
| Attachment | Size |
|---|---|
| Section II of the Enterprise Report of Activities, 2005-2007 | 420.38 KB |

Printable version